Leerink Partnrs Weighs in on The Cigna Group Q2 Earnings

The Cigna Group (NYSE:CI) – Analysts at Leerink Partnrs decreased their Q2 2025 EPS estimates for The Cigna Group in a research note issued to investors on Monday, November 4th. Leerink Partnrs analyst W. Mayo now expects that the health services provider will post earnings of $7.31 per share for the quarter, down from their previous forecast of $7.57. The consensus estimate for The Cigna Group’s current full-year earnings is $28.48 per share. Leerink Partnrs also issued estimates for The Cigna Group’s FY2026 earnings at $35.14 EPS, FY2027 earnings at $39.13 EPS and FY2028 earnings at $43.45 EPS.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business’s revenue was up 29.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.77 EPS.

Other analysts have also issued research reports about the company. Royal Bank of Canada lowered their price objective on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Stephens reissued an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a report on Friday, November 1st. Jefferies Financial Group raised their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. JPMorgan Chase & Co. increased their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Finally, Barclays lifted their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $394.64.

The Cigna Group Price Performance

NYSE:CI opened at $315.09 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a market cap of $87.64 billion, a P/E ratio of 29.73, a PEG ratio of 0.96 and a beta of 0.51. The company has a fifty day moving average price of $343.37 and a 200 day moving average price of $340.80. The Cigna Group has a one year low of $253.95 and a one year high of $370.83.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is 52.83%.

Insider Activity

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the sale, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On The Cigna Group

Several institutional investors have recently made changes to their positions in the stock. Cedar Wealth Management LLC purchased a new position in shares of The Cigna Group during the first quarter valued at approximately $29,000. TruNorth Capital Management LLC bought a new stake in shares of The Cigna Group in the 2nd quarter worth $33,000. Ulland Investment Advisors LLC raised its holdings in shares of The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group during the third quarter valued at about $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in The Cigna Group during the second quarter worth about $66,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.